CIK: 0001600175
Total reported value
$55.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 20.28% | — | -23.27% | |
| 2 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 6.29% | +0.81% | +11.86% | |
| 3 | IBB | Ishares Biotechnology ETF | ETF-Tech | 5.29% | +3.86% | — | |
| 4 | MRK | Merck & Co. INC. | Stock-Healthcare | 3.93% | — | — | |
| 5 | ALKS | Alkermes plc | Stock-Healthcare | 3.64% | +0.41% | NEW | |
| 6 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 2.95% | +0.27% | +1.45% | |
| 7 | PFE | Pfizer INC | Stock-Healthcare | 2.91% | — | — | |
| 8 | SGENEUR | Seagen INC | Stock-Other | 2.87% | +0.95% | +0.53% | |
| 9 | INCY | Incyte CORP | Stock-Healthcare | 2.80% | +0.10% | +1.17% | |
| 10 | BIB | Proshares Ultra Nasd Biotech | ETF-Tech | 2.70% | — | — | |
| 11 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 2.65% | +0.56% | +97.02% | |
| 12 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 2.61% | — | — | |
| 13 | CELG | Celgene CORP | Stock-Other | 2.52% | +0.24% | +1.59% | |
| 14 | QGEN | Qiagen N.V. | Stock-Healthcare | 2.49% | — | +1.01% | |
| 15 | BIIB | Biogen INC | Stock-Healthcare | 2.46% | — | +1.57% | |
| 16 | ALXN | Alexion Pharmaceuticals INC | Stock-Other | 2.43% | -0.16% | +1.64% | |
| 17 | MTD | Mettler-toledo International | Stock-Healthcare | 2.40% | +0.10% | — | |
| 18 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 2.25% | — | +2.29% | |
| 19 | AMGN | Amgen INC | Stock-Healthcare | 2.18% | — | +2.30% | |
| 20 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 2.08% | -0.01% | +3.07% | |
| 21 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 1.96% | +0.32% | +3.78% | |
| 22 | ILMN | Illumina INC | Stock-Healthcare | 1.94% | +0.04% | +3.08% | |
| 23 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 1.85% | -0.36% | EXIT | |
| 24 | GSK | GSK plc ADRhedged | Stock-Healthcare | 1.84% | — | — | |
| 25 | NKTREUR | Nektar Therapeutics | Stock-Other | 1.80% | -0.24% | +4.37% | |
| 26 | PCRX | Pacira Biosciences INC | Stock-Other | 1.29% | -0.72% | EXIT | |
| 27 | T8S | Tesaro INC | Stock-Other | 1.07% | — | — | |
| 28 | CLVSEUR | Clovis Oncology INC | Stock-Other | 1.06% | — | — | |
| 29 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 0.98% | — | — | |
| 30 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.88% | — | — | |
| 31 | ADMSEUR | Adamas Pharmaceuticals INC | Stock-Other | 0.81% | — | — | |
| 32 | MDCOUSD | Medicines Company | Stock-Other | 0.76% | — | — | |
| 33 | SNR1USD | New Senior Investment Group | Stock-Other | 0.65% | — | — | |
| 34 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 0.61% | -0.09% | +53.58% | |
| 35 | PTLAEUR | Portola Pharmaceuticals INC | Stock-Other | 0.45% | — | — | |
| 36 | CFRXEUR | Contrafect CORP | Stock-Other | 0.42% | — | — | |
| 37 | LABUUSD | Drx Dly S&p Biotech Bull 3x | ETF-Tech | 0.36% | -1.73% | -2.32% | |
| 38 | RAH | Societal Cdmo INC | Stock-Other | 0.26% | — | — | |
| 39 | ACAD | Acadia Pharmaceuticals INC | Stock-Healthcare | 0.23% | +0.31% | — | |
| 40 | UTHR | United Therapeutics CORP | Stock-Healthcare | 0.22% | +0.50% | NEW | |
| 41 | LION | Lionsgate Studios Corp. | Stock-Other | 0.22% | — | +65.07% | |
| 42 | GRFS | Grifols Sa-adr | Stock-Other | 0.21% | — | +40.21% | |
| 43 | LGND | Ligand Pharmaceuticals | Stock-Healthcare | 0.21% | — | — | |
| 44 | ✓ | Quintiles Transnational Holdin | Stock-Other | 0.21% | — | +25.20% | |
| 45 | TECH | Bio-techne CORP | Stock-Healthcare | 0.20% | — | — | |
| 46 | CRL | Charles River Laboratories | Stock-Healthcare | 0.20% | — | — | |
| 47 | GILD | Gilead Sciences INC | Stock-Healthcare | 0.19% | — | — | |
| 48 | KRG | Kite Realty Group Trust | Stock-Real Estate | 0.19% | — | — | |
| 49 | XONUSD | Intrexon CORP | Stock-Other | 0.19% | — | — | |
| 50 | ✓ | Avexis INC | Stock-Other | 0.19% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BMY | Bristol-myers Squibb Co | +2.6% | +11.86% | Add |
| 2 | ALKS | Alkermes plc | +1.5% | +0.76% | Add |
| 3 | IONS | Ionis Pharmaceuticals INC | +1.4% | +1.45% | Add |
| 4 | IBB | Ishares Biotechnology ETF | +1.2% | — | Unchanged |
| 5 | MRK | Merck & Co. INC. | +1% | — | Unchanged |
| 6 | INCY | Incyte CORP | +1% | +1.17% | Add |
| 7 | CELG | Celgene CORP | +1% | +1.59% | Add |
| 8 | ALNY | Alnylam Pharmaceuticals INC | +0.9% | +97.02% | Add |
| 9 | QGEN | Qiagen N.V. | +0.8% | +1.01% | Add |
| 10 | PFE | Pfizer INC | +0.8% | — | Unchanged |
| 11 | BIIB | Biogen INC | +0.6% | +1.57% | Add |
| 12 | REGN | Regeneron Pharmaceuticals | +0.6% | +2.29% | Add |
| 13 | BMRN | Biomarin Pharmaceutical INC | +0.5% | +3.07% | Add |
| 14 | AMGN | Amgen INC | +0.5% | +2.30% | Add |
| 15 | AZNN | Astrazeneca Plc-spons Adr | +0.4% | — | Unchanged |
| 16 | PRTKEUR | Paratek Pharmaceuticals INC | +0.4% | — | Unchanged |
| 17 | BIB | Proshares Ultra Nasd Biotech | +0.4% | — | Unchanged |
| 18 | VRTX | Vertex Pharmaceuticals INC | +0.4% | +3.78% | Add |
| 19 | GSK | GSK plc ADRhedged | +0.4% | — | Unchanged |
| 20 | RARE | Ultragenyx Pharmaceutical In | +0.3% | +53.58% | Add |
| 21 | PCRX | Pacira Biosciences INC | +0.3% | — | Unchanged |
| 22 | AGIO | Agios Pharmaceuticals INC | +0.2% | +1.52% | Add |
| 23 | MDCOUSD | Medicines Company | +0.2% | — | Unchanged |
| 24 | SNR1USD | New Senior Investment Group | +0.1% | — | Unchanged |
| 25 | LION | Lionsgate Studios Corp. | +0.1% | +65.07% | Add |
| 26 | NKTREUR | Nektar Therapeutics | +0.1% | +4.37% | Add |
| 27 | GRFS | Grifols Sa-adr | +0.1% | +40.21% | Add |
| 28 | UTHR | United Therapeutics CORP | +0.1% | +10.35% | Add |
| 29 | ILMN | Illumina INC | +0.1% | +3.08% | Add |
| 30 | CFRXEUR | Contrafect CORP | — | — | Unchanged |
| 31 | LABUUSD | Drx Dly S&p Biotech Bull 3x | 0% | -2.32% | Trim |
| 32 | XBI | Ss Spdr S&p Biotech ETF | -0.6% | -23.27% | Trim |
| 33 | IWM | Ishares Russell 2000 ETF | — | EXIT | Sold out |
| 34 | T8S | Tesaro INC | — | NEW | New buy |
| 35 | CLVSEUR | Clovis Oncology INC | — | NEW | New buy |
| 36 | LLY | Eli Lilly & Co | — | NEW | New buy |
| 37 | SDS | ProShares UltraShort S&P500 | — | EXIT | Sold out |
| 38 | RAH | Societal Cdmo INC | — | NEW | New buy |
| 39 | ✓ | Cepheid | — | EXIT | Sold out |
| 40 | ✓ | Ophthotech Corporation | — | EXIT | Sold out |
| 41 | ACAD | Acadia Pharmaceuticals INC | — | NEW | New buy |
| 42 | LGND | Ligand Pharmaceuticals | — | NEW | New buy |
| 43 | TECH | Bio-techne CORP | — | NEW | New buy |
| 44 | CRL | Charles River Laboratories | — | NEW | New buy |
| 45 | GILD | Gilead Sciences INC | — | NEW | New buy |
| 46 | KRG | Kite Realty Group Trust | — | NEW | New buy |
| 47 | XONUSD | Intrexon CORP | — | NEW | New buy |
| 48 | ✓ | Avexis INC | — | NEW | New buy |
| 49 | MYGN | Myriad Genetics INC | — | NEW | New buy |
| 50 | ✓ | Axovant Sciences LTD | — | EXIT | Sold out |